Cover Image

Design of randomized clinical trials with a binary endpoint: Conditional versus unconditional analyses of a two‐by‐two table

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Edward L. Korn, Boris Freidlin
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Statistics in Medicine
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Two‐stage randomized clinical trials with a right‐censored endpoint: Comparison of frequentist and Bayesian adaptive designs
by: Luana Boumendil, et al.
Published: (2024)

Use of win time for ordered composite endpoints in clinical trials
by: James F. Troendle, et al.
Published: (2024)

Doubly adaptive biased coin design to improve Bayesian clinical trials with time‐to‐event endpoints
by: Wenhao Cao, et al.
Published: (2024)

Dynamic path analysis for exploring treatment effect mediation processes in clinical trials with time‐to‐event endpoints
by: Matthias Kormaksson, et al.
Published: (2024)

Beyond the two‐trials rule
by: Leonhard Held
Published: (2024)

Correction to “Propensity score weighting for covariate adjustment in randomized clinical trials”
by: Shuxi Zeng, et al.
Published: (2024)

An information‐theoretic approach for the assessment of a continuous outcome as a surrogate for a binary true endpoint based on causal inference: Application to vaccine evaluation
by: Ariel Alonso Abad, et al.
Published: (2024)

Understanding an impact of patient enrollment pattern on predictability of central (unstratified) randomization in a multi‐center clinical trial
by: Johannes Krisam, et al.
Published: (2024)

Are the tests overpowered or underpowered? A unified solution to correctly specify type I errors in design of clinical trials for two sample proportions
by: Peiran Liu, et al.
Published: (2024)

Assurance methods for designing a clinical trial with a delayed treatment effect
by: James A. Salsbury, et al.
Published: (2024)

Design and sample size determination for multiple‐dose randomized phase II trials for dose optimization
by: Peng Yang, et al.
Published: (2024)

A two‐stage group‐sequential design for delayed treatment responses with the possibility of trial restart
by: Stephen Schüürhuis, et al.
Published: (2024)

Determining sample size in a personalized randomized controlled (PRACTical) trial
by: Rebecca M. Turner, et al.
Published: (2024)

A sequential, multiple assignment, randomized trial design with a tailoring function
by: Holly Hartman, et al.
Published: (2024)

Correction to “Using principal stratification in analysis of clinical trials”
by: Ilya Lipkovich, et al.
Published: (2024)

Sample size calculation for comparing two screening tests when the gold standard is missing at random
by: Yougui Wu
Published: (2024)

Confidence distributions for treatment effects in clinical trials: Posteriors without priors
by: Ian C. Marschner
Published: (2024)

Evaluating analytic models for individually randomized group treatment trials with complex clustering in nested and crossed designs
by: Jonathan C. Moyer, et al.
Published: (2024)

Group sequential designs for clinical trials when the maximum sample size is uncertain
by: Amin Yarahmadi, et al.
Published: (2024)

Comparison of methods that combine multiple randomized trials to estimate heterogeneous treatment effects
by: Carly Lupton Brantner, et al.
Published: (2024)

Confidence intervals for odds ratio from multistage randomized phase II trials
by: Shiwei Cao, et al.
Published: (2024)

Multiply robust generalized estimating equations for cluster randomized trials with missing outcomes
by: Dustin J. Rabideau, et al.
Published: (2024)

Fractional accumulative calibration‐free odds (f‐aCFO) design for delayed toxicity in phase I clinical trials
by: Jialu Fang, et al.
Published: (2024)

A unified Bayesian framework for bias adjustment in multiple comparisons from clinical trials
by: Yu Du, et al.
Published: (2024)

Dual‐agent dose‐finding in Phase I clinical trial—An extension of rapid enrollment design
by: Yunfei Wang
Published: (2024)

A hybrid approach to sample size re‐estimation in cluster randomized trials with continuous outcomes
by: Samuel K Sarkodie, et al.
Published: (2024)

A class of computational methods to reduce selection bias when designing Phase 3 clinical trials
by: Tianyu Zhan
Published: (2024)

Comparing two hazard curves when there is a treatment time‐lag effect
by: Xiaoxi Zhang, et al.
Published: (2024)

Improved mortality analysis in early‐phase dose‐ranging clinical trials for emergency medical diseases using Bayesian time‐to‐event models with active comparators
by: Xiaosong Shi, et al.
Published: (2024)

Assessing efficacy in non‐inferiority trials with non‐adherence to interventions: Are intention‐to‐treat and per‐protocol analyses fit for purpose?
by: Matthew Dodd, et al.
Published: (2024)

Enhancing long‐term survival prediction with two short‐term events: Landmarking with a flexible varying coefficient model
by: Wen Li, et al.
Published: (2024)

A latent variable approach to jointly modeling longitudinal and cumulative event data using a weighted two‐stage method
by: Madeline R. Abbott, et al.
Published: (2024)

Bridging the gap between two‐stage and joint models: The case of tumor growth inhibition and overall survival models
by: Danilo Alvares, et al.
Published: (2024)

Generalized single index modeling of longitudinal data with multiple binary responses
by: Zibo Tian, et al.
Published: (2024)

Multivariate probit linear mixed models for multivariate longitudinal binary data
by: Kuo‐Jung Lee, et al.
Published: (2024)

A Bayesian Approach to the G‐Formula via Iterative Conditional Regression
by: Ruyi Liu, et al.
Published: (2025)

Robust analysis of stepped wedge trials using composite likelihood models
by: Emily C. Voldal, et al.
Published: (2024)

Modeling intra‐individual inter‐trial EEG response variability in autism
by: Mingfei Dong, et al.
Published: (2024)

Statistical considerations in model‐based dose finding for binary responses under model uncertainty
by: Zhiwu Yan, et al.
Published: (2024)

Sensitivity analysis with iterative outlier detection for systematic reviews and meta‐analyses
by: Zhuo Meng, et al.
Published: (2024)